Skip to main content
. 2021 Dec 20;2021:4014601. doi: 10.1155/2021/4014601

Figure 5.

Figure 5

mPFS in patients with metastatic colorectal cancer treated with TAS-102 monotherapy or combination therapy with bevacizumab.